Isolation, structure elucidation, and synthesis of a macrophage stimulatory lipopeptide from Mycoplasma fermentans acting at picomolar concentration

被引:347
作者
Muhlradt, PF
Kiess, M
Meyer, H
Sussmuth, R
Jung, G
机构
[1] GESELL BIOTECHNOL FORSCH MBH,STRUCT RES GRP,D-38124 BRAUNSCHWEIG,GERMANY
[2] UNIV TUBINGEN,INST ORGAN CHEM,D-72076 TUBINGEN,GERMANY
关键词
D O I
10.1084/jem.185.11.1951
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Macrophages are typically stimulated by components of microbial cell walls. Surprisingly, cell wall-less mycoplasmas can also very efficiently stimulate macrophages. We showed recently that mycoplasma-derived lipopeptides constitute the active principle. We have now isolated a clone of Mycoplasma fermentans expressing mainly one macrophage-stimulating lipopeptide. This lipopeptide was detergent-extracted and isolated by reversed-phase high-performance liquid chromotography, using nitric oxide release from C3H/HeJ mouse macrophages as bioassay for detection. In contrast to ''conventional'' bacterial Lipoproteins, this lipopeptide had a free NH2 terminus. Amino acid composition, sequence, and the molecular weight of 2,163.3 are consistent with the following structure: S-(2,3-bisacyloxypropyl)cysteine-GNNDESNISFKEK with one mole C16:0, and a further mole of a mixture of C18:0 and C18:1 fatty acid per Lipopeptide molecule. The sequence could not be found in either the protein identification resource nor the Swiss Prot data bank. We named this 2-kD Lipopeptide, macrophage-activating lipopeptide-2 (MALP-2). Synthetic dipalmitoyl MALP-2 and mycoplasma-derived MALP-2 were compared with the bioassay. Both lipopeptides showed an identical dose dependency with a half-maximal response at 10(-11) M concentration. MALP-2 may be one of the most potent natural macrophage stimulators besides endotoxin.
引用
收藏
页码:1951 / 1958
页数:8
相关论文
共 52 条
[1]  
BARILE MF, 1991, REV INFECT DIS, V13, P571
[2]   MURAMYLPEPTIDES AND LIPOPEPTIDES - STUDIES TOWARDS IMMUNOSTIMULANTS [J].
BASCHANG, G .
TETRAHEDRON, 1989, 45 (20) :6331-6360
[3]   RELEASE OF ENDOGENOUS PYROGEN BY HUMAN MONOCYTES [J].
BODEL, P ;
ATKINS, E .
NEW ENGLAND JOURNAL OF MEDICINE, 1967, 276 (18) :1002-+
[4]   EFFICACY OF SYNTHETIC VACCINES IN THE INDUCTION OF CYTOTOXIC T-LYMPHOCYTES - COMPARISON OF THE COSTIMULATING SUPPORT PROVIDED BY HELPER T-CELLS AND LIPOAMINO ACID [J].
BORGES, E ;
WIESMULLER, KH ;
JUNG, G ;
WALDEN, P .
JOURNAL OF IMMUNOLOGICAL METHODS, 1994, 173 (02) :253-263
[5]  
Braun V., 1994, Bacterial cell wall, P319
[6]   Influence of matrix solution conditions on the MALDI-MS analysis of peptides and proteins [J].
Cohen, SL ;
Chait, BT .
ANALYTICAL CHEMISTRY, 1996, 68 (01) :31-37
[7]  
Cole B. C., 1985, The mycoplasmas. Volume IV. Mycoplasma pathogenicity, P107
[8]   The sequence of the Mycoplasma arthritidis superantigen, MAM: Identification of functional domains and comparison with microbial superantigens and plant lectin mitogens [J].
Cole, BC ;
Knudtson, KL ;
Oliphant, A ;
Sawitzke, AD ;
Pole, A ;
Manohar, M ;
Benson, LS ;
Ahmed, E ;
Atkin, CL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (03) :1105-1110
[9]   INVIVO PRIMING OF VIRUS-SPECIFIC CYTO-TOXIC LYMPHOCYTES-T WITH SYNTHETIC LIPOPEPTIDE VACCINE [J].
DERES, K ;
SCHILD, H ;
WIESMULLER, KH ;
JUNG, G ;
RAMMENSEE, HG .
NATURE, 1989, 342 (6249) :561-564
[10]   TYROSINE PHOSPHORYLATION OF MITOGEN-ACTIVATED PROTEIN-KINASES IS NECESSARY FOR ACTIVATION OF MURINE MACROPHAGES BY NATURAL AND SYNTHETIC BACTERIAL PRODUCTS [J].
DONG, ZY ;
QI, XX ;
FIDLER, IJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (04) :1071-1077